A New Once-Weekly Insulin — Its Effectiveness and Safety
Type 2 diabetes is a common yet complex disorder in which the key hormone for nutrient storage, insulin, is both ineffective and insufficient in...
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
In a phase 3 trial, adults with type 2 diabetes who had not previously received insulin were assigned to receive once-weekly efsitora or once-daily...
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
In a phase 3 trial, adults with type 2 diabetes who had not previously received insulin were assigned to receive once-weekly efsitora or once-daily...
Making Long-Term Oxygen Therapy Less Burdensome
Long-term oxygen therapy, the first intervention that was shown to improve survival in patients with both severe hypoxemia and chronic obstructive pulmonary disease (COPD),...
Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia
Oxygen therapy prolongs survival in patients with severe hypoxemia but is a burden. In this trial, therapy for 24 rather than 15 hours per...
